New plague vaccine enters human testing
⭐️ VACCINE ⭐️
Recruiting now
This study tests a new vaccine called rF1V-1018 to prevent pneumonic plague, a severe lung infection spread by aerosol. Researchers will give the vaccine to 148 healthy adults aged 18 to 55 to check if it triggers a strong immune response and is safe. The goal is to find the best…
Phase: PHASE2 • Sponsor: Dynavax Technologies Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:00 UTC